Southern CDC & Guardant Health AMEA
Southern CDC is now the official commercial partner for Guardant Health in Australia. We are committed to transforming patient care and accelerating new cancer therapies by providing critical insights into what drive disease through blood and tissue tests, real-world data and Al analytics.
Unlocking Insights to Help Find, Treat, and Monitor Cancer
Today, our tests expand the potential of precision oncology–targeting therapy based on molecular characteristics of the individual’s tumor–by unlocking critical insights into what drives cancer.
Our tests can improve patient outcomes across all stages of cancer, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer.
Our Products
Our blood and tissue tests provide insights that can improve patient outcomes throughout the cancer journey.
Guardant Complete
Guiding treatment decisions in advanced cancer and recurrence monitoring in early-stage cancer.
